A Study to Investigate the Safety and Efficacy of Optivate® in Children Under 6 Years of Age With Haemophilia A.

NCT02246894 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Haemophilia A

Interventions

BIOLOGICAL: Optivate® (Human Coagulation Factor VIII)

Sponsor

Bio Products Laboratory